wet- en regelgeving Vertex’s Orkambi receives European approval to treat children with CF aged 2 to 5 years old with most common form of disease 22 januari 2019Pharma Biz
wet- en regelgeving Samsung Bioepis oncology biosimilar Ontruzant receives US FDA approval 22 januari 2019Pharma Biz
wet- en regelgeving Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test 21 januari 2019FiercePharma
wet- en regelgeving Therachon gets US FDA orphan drug status for apraglutide for short bowel syndrome treatment 21 januari 2019Pharma Biz
wet- en regelgeving Europe closer to biosimilar rule change, despite fierce resistance from pharma 21 januari 2019PMLiVE